. . . . . . . . . . . . . . . "kin(p(HGNC:ERBB2)) -> p(HGNC:TGFA)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Herceptin treatment of ErbB2 overexpressing tumor cells decreases expression of proangiogeneic factors including VEGF and TGF-alpha, resulting in a dramatic change in the tumor vasculature and a decrease in tumor size [123]." . . "Selventa" . . . . "2014-07-03T14:30:11.186+02:00"^^ . . .